Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
Inclusion Criteria
- Patients who have got FFMI (bioimpedance)
- Patients who have done quadriceps muscle strenght evaluation
- Patients who have got FFMI (bioimpedance)
- Patients who have done quadriceps muscle strenght evaluation
Exclusion Criteria
- Patients without quadriceps muscle strenght
- Patients without FFMI
- Patients without quadriceps muscle strenght
- Patients without FFMI
Summary
- Conditions
- COPD
- Type
- Observational
- Design
- Observational Model: Cohort
- Time Perspective: Retrospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Inclusion Criteria
- Patients who have got FFMI (bioimpedance)
- Patients who have done quadriceps muscle strenght evaluation
- Patients who have got FFMI (bioimpedance)
- Patients who have done quadriceps muscle strenght evaluation
Exclusion Criteria
- Patients without quadriceps muscle strenght
- Patients without FFMI
- Patients without quadriceps muscle strenght
- Patients without FFMI
Tracking Information
- NCT #
- NCT02080936
- Collaborators
- Not Provided
- Investigators
- Not Provided